Zobrazeno 1 - 10
of 178
pro vyhledávání: '"Christine, Wolschke"'
Autor:
Luise Brakert, Laura Berneking, Anna Both, Benjamin Berinson, Jiabin Huang, Martin Aepfelbacher, Christine Wolschke, Dominic Wichmann, Holger Rohde
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 34, Iss , Pp 59-62 (2023)
ABSTRACT: Here we report the in vivo development of cefiderocol resistance within 11 days after therapy initiation in a critically ill patient with bloodstream infection, infection of peri-anal fistula, and pneumonia caused by a VIM-2 harbouring, car
Externí odkaz:
https://doaj.org/article/6582fdc93c7d4773b8f4f75f58b35258
Autor:
Nicolaus Kröger, Gerald Wulf, Ute Hegenbart, Andreas Burchert, Matthias Stelljes, Nico Gagelmann, Arne Brecht, Martin Kaufmann, Lutz Müller, Arnold Ganser, Dominik Wolf, Wolfgang Bethge, Martin Bornhäuser, Michael Kiehl, Eva-Maria Wagner, Christoph Schmid, Hans Christian Reinhardt, Guido Kobbe, Hans Salwender, Thomas Heinicke, Martin Kropff, Marion Heinzelmann, Francis Ayuk, Lorenz Trümper, Andreas Neubauer, Andreas Völp, Evgeny Kluychnikov, Stefan Schönland, Christine Wolschke
Publikováno v:
Haematologica, Vol 109, Iss 5 (2023)
The role of autologous-allogeneic tandem stem cell transplantation (alloTSCT) followed by maintenance as upfront treatment for multiple myeloma is controversial. Between 2008 and 2014 a total of 217 multiple myeloma patients with a median age of 51 y
Externí odkaz:
https://doaj.org/article/d16b172f3b0d40de80f3b187f9e3c4b7
Publikováno v:
Clinical Case Reports, Vol 11, Iss 9, Pp n/a-n/a (2023)
Key Clinical Message Here, we describe a patient with post‐transplant myelofibrosis with chronic graft‐versus‐host disease (GVHD), who showed successful molecular remission with ropeginterferon with 100% donor chimerism without any flare up of
Externí odkaz:
https://doaj.org/article/9ea5769657de48ba8a61a5d30a833dab
Autor:
Nico Gagelmann, Christine Wolschke, Anita Badbaran, Dietlinde Janson, Carolina Berger, Evgeny Klyuchnikov, Francis Ayuk, Boris Fehse, Nicolaus Kröger
Publikováno v:
HemaSphere, Vol 7, Iss 7, p e921 (2023)
Hematopoietic cell transplantation (HCT) is a curative approach for myelofibrosis patients, but relapse is a major cause of treatment failure. We investigated the effect of donor lymphocyte infusion (DLI) in 37 patients with molecular (n = 17) or hem
Externí odkaz:
https://doaj.org/article/0cb54fc977df4ed1a50b95c2ca9dd72e
Autor:
Gunnar Weise, Radwan Massoud, Rolf Krause, Silke Heidenreich, Dietlinde Janson, Evgeny Klyuchnikov, Christine Wolschke, Gaby Zeck, Nicolaus Kröger, Francis Ayuk
Publikováno v:
Cancers, Vol 16, Iss 3, p 515 (2024)
We aimed to develop a concise objectifiable risk evaluation (CORE) tool for predicting non-relapse mortality (NRM) and overall survival (OS) after allogeneic hematopoietic stem cell transplantation (allo-HCT). A total of 1120 adult patients who had u
Externí odkaz:
https://doaj.org/article/4a0b0e52708a40bdbee71c0eb9d1f513
Autor:
Nico Gagelmann, Francis A. Ayuk, Evgeny Klyuchnikov, Christine Wolschke, Susanna Carolina Berger, Nicolaus Kröger
Publikováno v:
Haematologica, Vol 108, Iss 10 (2023)
Externí odkaz:
https://doaj.org/article/6500714330dc4e408008243ae395b75c
Autor:
Nico Gagelmann, Rachel B. Salit, Thomas Schroeder, Anita Badbaran, Christina Rautenberg, Victoria Panagiota, Christine Wolschke, Felicitas Thol, Bruno Cassinat, Marie Robin, Michael Heuser, Hans Christian Reinhardt, Bart L. Scott, Nicolaus Kröger
Publikováno v:
HemaSphere, Vol 6, Iss 10, p e784 (2022)
There is no direct evidence to recommend specific conditioning intensities in myelofibrosis undergoing allogeneic hematopoietic cell transplantation, especially in the molecular era. We aimed to compare outcomes of reduced intensity (RIC) or myeloabl
Externí odkaz:
https://doaj.org/article/dd0918fa569643839a6527ee21f4bb20
Autor:
Susanna Carolina Berger, Boris Fehse, Nuray Akyüz, Maria Geffken, Christine Wolschke, Dietlinde Janson, Nico Gagelmann, Marlene Luther, Dominic Wichmann, Christian Frenzel, Guenther Thayssen, Anna Alegiani, Anita Badbaran, Silke Zeschke, Judith Dierlamm, Nicolaus Kröger, Francis A. Ayuk
Publikováno v:
Haematologica, Vol 108, Iss 2 (2022)
CD19-specific chimeric antigen receptor (CD19-CAR) T-cell therapies mediate durable responses in late-stage B-cell malignancies, but can be complicated by a potentially severe immune effector cell-associated neurotoxicity syndrome (ICANS). Despite br
Externí odkaz:
https://doaj.org/article/6a291010901a42279b07877a1f0e54c0
Autor:
Vivien Häußler, Friederike Ufer, Jana Pöttgen, Christine Wolschke, Manuel A. Friese, Nicolaus Kröger, Christoph Heesen, Jan‐Patrick Stellmann
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 8, Iss 6, Pp 1269-1278 (2021)
Abstract Objective Autologous hematopoietic stem cell transplantation (aHSCT) is increasingly recognized as a potential therapy for patients with highly active multiple sclerosis (MS). This study aims to assess outcome differences in disease activity
Externí odkaz:
https://doaj.org/article/96a40fa750014c9e84c1963b7b94bb74
Autor:
Nico Gagelmann, Francesco Passamonti, Christine Wolschke, Radwan Massoud, Christian Niederwieser, Raissa Adjallé, Barbara Mora, Francis Ayuk, Nicolaus Kröger
Publikováno v:
Haematologica, Vol 107, Iss 8 (2021)
Vaccines against SARS-CoV-2 have shown remarkable efficacy and thus constitute an important preventive option against coronavirus disease 2019 (COVID-19), especially in fragile patients. We aimed to systematically analyze the outcomes of patients wit
Externí odkaz:
https://doaj.org/article/f2675490b919466db928f765219a82eb